Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Minimally Invasive Urinary Incontinence Device Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The minimally invasive urinary incontinence device market has demonstrated robust growth in recent years. It will grow from $1.25 billion in 2025 to $1.37 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be attributed to factors like the reliance on traditional open surgical procedures, restricted availability of device options for urinary incontinence, increasing awareness of female pelvic health, a rise in hospital and clinic-based procedures, and the adoption of tension-free vaginal tape (TVT) systems.
The minimally invasive urinary incontinence device market size is anticipated to undergo robust expansion in the upcoming years. It is projected to reach $1.91 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.8%. The impetus for this growth in the forecast period stems from factors such as the advancement of mid-urethral and single-incision sling systems, increased financial backing for home healthcare devices, an expanding elderly population coupled with a rising prevalence of incontinence, regulatory sanctions for innovative bulking agents and artificial urinary sphincters, and the incorporation of smart and robotic-assisted surgical systems. Prominent trends throughout the forecast period include a heightened adoption of minimally invasive surgical procedures, an increase in urinary incontinence cases driven by an aging demographic, a rising preference for home healthcare management, the broadening use of mid-urethral sling and sling systems, and a concerted effort to shorten recovery times and lessen surgical complications.
Get A Free Sample Report With In-Depth Market Insights:
Minimally Invasive Urinary Incontinence Device Market Growth Factors: What’s Supporting Expansion?
The increasing occurrence of prostate cancer is projected to stimulate the growth of the minimally invasive urinary incontinence device market moving forward. This condition involves the uncontrolled proliferation of cells within the prostate gland, which can affect urinary and reproductive health. The rising incidence of prostate cancer is largely influenced by an aging male population, as older age presents a significant risk factor for the disease. Minimally invasive urinary incontinence devices are instrumental in managing urinary complications linked to prostate cancer by providing targeted support to control bladder leakage, restore normal urinary function, and markedly improve the overall quality of life for patients undergoing treatment or recovery. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 255,395 new cases of prostate cancer were diagnosed in the United States in 2022, and in 2023, the disease was responsible for the deaths of approximately 33,881 men. Therefore, the expanding incidence of prostate cancer is propelling the growth of the minimally invasive urinary incontinence device market.
Minimally Invasive Urinary Incontinence Device Market Segment Landscape And Growth Outlook
The minimally invasive urinary incontinence device market covered in this report is segmented –
1) By Type: Tension Free Vaginal Tape (TVT), Tension Free Vaginal Tape (TVT) Obturator System, Other Types
2) By Age Group: Adults (18-65 years), Senior Population (65 Years And Above), Pediatric Population
3) By End-User: Hospitals, Clinics, Home Healthcare Settings, Research Institutions
Subsegments:
1) By Tension Free Vaginal Tape (TVT): Mid Urethral Sling, Retropubic Sling, Single Incision Sling
2) By Tension Free Vaginal Tape Obturator System (TVTO): Inside Out Approach, Outside In Approach
3) By Other Types: Bulking Agents, Artificial Urinary Sphincter, Sling Systems
Minimally Invasive Urinary Incontinence Device Market Industry Trends: What’s Reshaping Demand?
Major companies operating in the minimally invasive urinary incontinence device market are concentrating on developing advanced products such as neuromodulation therapy devices, with the goal of providing effective, long-term solutions that involve minimal surgical intervention. Neuromodulation therapy devices are implants designed to activate bladder-controlling nerves, thereby regulating urinary function and assisting in the management of incontinence by enhancing bladder control and reducing accidental leakage. For instance, in December 2023, BlueWind Medical Ltd., a US-based company specializing in neurostimulation devices, launched its Revi implantable tibial neuromodulation (iTNM) device. This device is a battery-free, minimally invasive implant engineered to treat urge urinary incontinence (UUI) by stimulating the posterior tibial nerve. The device is implanted near the ankle during a single outpatient procedure under local anesthesia and is activated using a lightweight wearable, which allows patients to conveniently manage their symptoms at home. This launch highlights the ongoing trend of introducing innovative, patient-friendly neuromodulation solutions within the urinary incontinence device market.
Minimally Invasive Urinary Incontinence Device Market Industry Leaders And Competitive Landscape
Major companies operating in the minimally invasive urinary incontinence device market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Teleflex Incorporated, Hollister Incorporated, CooperSurgical Inc., B. Braun Melsungen Aktiengesellschaft, LiNA Medical ApS, BlueWind Medical Ltd., Caldera Medical Inc., Neuspera Medical Inc., InControl Medical LLC, UroMems Inc., Rigicon Inc., Valencia Technologies Corporation, Zephyr Surgical Implants SA
View The Full Minimally Invasive Urinary Incontinence Device Market Report:
Minimally Invasive Urinary Incontinence Device Market Regional Analysis And Leading Geography
North America was the largest region in the minimally invasive urinary incontinence device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive urinary incontinence device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
